Application of octenidine in inhibiting acetyltransferase and resisting mycobacterium infection
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- TIANJIN INT JOINT ACADEMY OF BIOTECH & MEDICINE
- Publication Date
- 2020-02-14
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of pharmacy, in particular to the application of octenidine in inhibiting acetyltransferase and resisting mycobacterium infection. Background technique
[0002] Tuberculosis (TB) is an infectious disease caused by Mycobacterium tubercuosis (Mtb). It is mainly transmitted through the respiratory tract and can cause symptoms such as cough, chest pain, hemoptysis, and dyspnea. It occurs when the body's immunity is weakened. According to estimates by the World Health Organization, despite vigorous efforts to curb tuberculosis infection worldwide, 10.4 million new patients develop tuberculosis (TB) each year, resulting in approximately 1.5 million deaths worldwide each year. In 1993, WHO declared a "global tuberculosis emergency", arguing that tuberculosis has become an important public health problem all over the world.
[0003] Tuberculosis was discovered in 1882 by German microbiologist Robert Koch. Microsc...